| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |